Efficacy
78
13
16
28
Key Insights
Highlights
Success Rate
97% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
1.3%
1 terminated out of 78 trials
96.6%
+10.0% vs benchmark
24%
19 trials in Phase 3/4
18%
5 of 28 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 28 completed trials
Clinical Trials (78)
Intrastromal Injection of Fluconazole in Treatment of Fungal Keratitis
Bilateral Peribulbar Block for Cataract Surgery
Safety and Efficacy of Distal Radial Access (SAFE-BOX)
GARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd Dose
Human Amniotic-Derived Mesenchymal Stem Cell Therapy for Calciphylaxis
Phase 1/2 Study of HYP-2090PTSA in Patients With Advanced Solid Tumors Harboring KRAS Mutation
Phase 1/2 Clinical Study of HY07121 Powder for Solution for Infusion in Patients With Advanced Solid Tumors
Clinical Study on the Effectiveness of Diverse Segments Defocus Optimization in Spectacle Lenses for Slowing Myopia Progression
A Study of GC101 TIL in Advanced Melanoma (BZ)
A Phase I Study of GC101 TIL in Advanced Solid Tumors
Safety and Early Efficacy of iPSC-Derived Motor Neuron Progenitor Cells (XS228) in Subacute Spinal Cord Injury: A Phase I Trial
Efficacy of iPSC-Derived Motor Neuron Cells (XS228) in Subacute Spinal Cord Injury: A Phase II Randomized Controlled Trial
Induction Immuno-chemotherapy and Concurrent Chemoradiotherapy With or Without Apatinib in Unresectable, Locally Advanced Esophageal Squamous Cell Carcinoma
Evaluation of the Efficacy and Safety of Megestrol Acetate in Preventing Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy
Midazolam Efficacy/Safety in Pre-Eclamptic C-Section Sedation
The OPTIMAL TDM Study: Determining Optimal Beta-lactam Plasma Concentrations Through Therapeutic Drug Monitoring
Combination of Ertugliflozin And Sitagliptin Efficacy, Safety & Tolerability (CEASE Diabetes) Study
Effect of Vitamin D Supplementation on the Efficacy and Adverse Effects of Neoadjuvant Therapy in Patients with Breast Cancer
Study of the Clinical Benefits of Different Formulations of Amphotericin B
AK112 Plus Platinum-based Chemotherapy for EGFR/ALK/ROS1 Positve NSCLC